We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$418M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$235M
3
EXEL icon
Exelixis
EXEL
+$219M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$191M
5
SJR
Shaw Communications Inc.
SJR
+$183M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$152M
2
CLVT icon
Clarivate
CLVT
+$127M
3
SGFY
Signify Health, Inc.
SGFY
+$113M
4
LHCG
LHC Group LLC
LHCG
+$111M
5
ATVI
Activision Blizzard
ATVI
+$87M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSP icon
51
Inspire Medical Systems
INSP
$1.74B
$56.8M 0.31%
242,596
– –
AGIO icon
52
Agios Pharmaceuticals
AGIO
$1.93B
$48.1M 0.26%
2,092,829
+67,000
+3% +$1.78M
SIMO icon
53
Silicon Motion
SIMO
$8.68B
$46.2M 0.25%
705,000
-226,510
-24% -$14.9M
SGEN
54
DELISTED
Seagen Inc. Common Stock
SGEN
$45.6M 0.25%
+225,000
New +$36.1M
TSEM icon
55
Tower Semiconductor
TSEM
$28.5B
$41.4M 0.23%
975,000
-640,000
-40% -$26.7M
HCA icon
56
HCA Healthcare
HCA
$89.5B
$41.3M 0.23%
+156,600
New +$39.8M
MDGL icon
57
Madrigal Pharmaceuticals
MDGL
$11.8B
$39.7M 0.22%
163,819
+10,819
+7% +$2.95M
BRKR icon
58
Bruker
BRKR
$8.14B
$39M 0.21%
494,476
-364,824
-42% -$26.3M
EVH icon
59
Evolent Health
EVH
$447M
$37.1M 0.2%
1,143,909
+841,909
+279% +$26.6M
NTRA icon
60
Natera
NTRA
$46.4B
$36.7M 0.2%
661,783
+518,583
+362% +$24.9M
CYTK icon
61
Cytokinetics
CYTK
$10.4B
$33M 0.18%
938,072
-763,666
-45% -$31.2M
RETA
62
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$29.5M 0.16%
325,000
-7,000
-2% -$411K
KVSC
63
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$28.5M 0.16%
2,809,000
– –
MTAL
64
DELISTED
Metals Acquisition
MTAL
$25.4M 0.14%
2,489,700
– –
BACA
65
DELISTED
Berenson Acquisition Corp. I
BACA
$24.9M 0.14%
2,475,000
– –
THC icon
66
Tenet Healthcare
THC
$21.1B
$23.1M 0.13%
+389,000
New +$21.6M
JAZZ icon
67
Jazz Pharmaceuticals
JAZZ
$16.7B
$21.9M 0.12%
150,000
-79,800
-35% -$11.8M
SVRA icon
68
Savara
SVRA
$1.19B
$21.3M 0.12%
10,908,086
+773,125
+8% +$1.74M
APLS
69
DELISTED
Apellis Pharmaceuticals
APLS
$20.9M 0.11%
317,553
-132,847
-29% -$7.67M
MAXR
70
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$20.4M 0.11%
+400,000
New +$20.5M
IVCP
71
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$20.4M 0.11%
1,980,000
– –
ZYME icon
72
Zymeworks
ZYME
$1.67B
$18.1M 0.1%
2,000,000
+500,000
+33% +$4.36M
SEDA
73
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$17.8M 0.1%
1,732,500
– –
BNTX icon
74
BioNTech
BNTX
$23.5B
$17.1M 0.09%
137,644
-2,356
-2% -$323K
SYNH
75
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$16.8M 0.09%
+472,000
New +$17.1M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Farallon Capital Management held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in UnitedHealth worth $409M.

  • Farallon Capital Management's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Farallon Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Farallon Capital Management fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Farallon Capital Management opened 14 new positions and closed 63 in Q1 2023.
  • Farallon Capital Management's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.